International education in Cannabinoid Therapy.
The Institute provides professional education for healthcare professionals, researchers, educators and policymakers. It does not provide individual medical advice, clinical services or medicinal cannabis products.
Medicinal cannabis is emerging as a legitimate and legal therapeutic domain in many jurisdictions, in which the strength and applicability of evidence vary by cannabinoid, product, formulation, dose, route of administration and clinical indication. Cannabis has a long history of therapeutic use and is undergoing renewed scientific and clinical evaluation; historical use does not replace modern evidence appraisal.
Patients may use cannabinoid products under medical supervision, through other lawful access pathways, or without clinical supervision. Healthcare professionals therefore need sufficient knowledge to ask about use, recognise potential benefits and limitations, adverse effects, contraindications and interactions, interpret emerging evidence, and respond within their professional scope and local regulatory framework.
Researchers, educators and policymakers also have a responsibility to remain informed as evidence, products and regulatory frameworks evolve.
To advance international professional education in the science and clinical practice of Cannabinoid Therapy.
A global community of practitioners equipped to make evidence-informed, responsible and safe decisions concerning cannabinoid products.
Rigorous, evidence-based curriculum authored by practising clinicians and scientists, delivered under academic direction.
Curriculum development distinguishes regulator-approved uses, clinical trials, observational evidence, preclinical findings, mechanistic hypotheses and areas of insufficient evidence.
Educators from multiple jurisdictions ensure a genuinely comparative and global perspective.
Curriculum direction, module content and teaching are set by our academic leadership. Any future sponsored educational material will be identified transparently and will not transfer control of curriculum or conclusions to a sponsor.